lamivudine has been researched along with Leukemia, Myeloid, Acute in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CH; Chiang, LT; Ko, BS; Yao, M | 1 |
| Cutz, E; Petric, M; Roberts, EA; Yeung, LT | 1 |
| Berenberg, JL; Mills, SJ; Ramos, F | 1 |
| Aki, SZ; Aköz, AG; Ayli, M; Dagdas, S; Güler, N; Özet, G; Saritas, U; Yilmaz, M | 1 |
| Antonio, G; Federica, S; Giuseppe, L; Luca, L; Michela, T; Nicola, P; Paola, P; Patrizia, C; Simona, S | 1 |
| Fouillard, L; Gozlan, J; Serfaty, L | 1 |
| Gondo, H; Himeji, D; Kaji, Y; Niho, Y; Sata, M; Uchida, N | 1 |
1 review(s) available for lamivudine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Lamivudine prophylaxis for chemotherapy induced reactivation hepatitis B: a case report and review.
Topics: Adult; Antineoplastic Protocols; Female; Hepatitis B; Humans; Lamivudine; Leukemia, Myeloid, Acute; Reverse Transcriptase Inhibitors | 2003 |
6 other study(ies) available for lamivudine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Development of immunity against hepatitis B virus after donor lymphocyte infusion in a peripheral blood stem cell transplantation recipient with chronic hepatitis B.
Topics: Adenine; Adoptive Transfer; Antiviral Agents; DNA, Viral; Drug Combinations; Female; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Leukemia, Myeloid, Acute; Lymphocyte Transfusion; Middle Aged; Organophosphonates; Peripheral Blood Stem Cell Transplantation; Taiwan; Treatment Outcome; Unrelated Donors | 2011 |
Histological improvement with lamivudine therapy for de novo hepatitis B occurring in an anti-HBs-positive child after bone marrow transplantation.
Topics: Adolescent; Antibodies, Viral; Bone Marrow Transplantation; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Leukemia, Myeloid, Acute; Liver Cirrhosis; Virus Activation | 2002 |
Lamivudine therapy in acute leukemia patients who are hepatitis B surface antigen carriers.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Reverse Transcriptase Inhibitors; Young Adult | 2003 |
Treatment of an HBs-Ag positive stem cell donor with lamivudine to prevent the development of hepatitis B in the recipient.
Topics: Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Leukemia, Myeloid, Acute; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stem Cell Transplantation; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 2004 |
Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation.
Topics: Adenine; Adult; Antineoplastic Agents; Combined Modality Therapy; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Leukemia, Myeloid, Acute; Organophosphonates; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Viral Load; Virus Activation | 2006 |
Lamivudine therapy for a hepatitis B surface antigen (HBsAg)-positive leukemia patient receiving myeloablative chemotherapy and autologous stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Combined Modality Therapy; DNA, Viral; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Leukemia, Myeloid, Acute; Liver Failure; Male; Reverse Transcriptase Inhibitors | 2000 |